Target type: biologicalprocess
Any process that activates or increases the frequency, rate or extent of catalase activity. [GOC:TermGenie, PMID:24285797]
Positive regulation of catalase activity is a complex process that involves a cascade of molecular events aimed at increasing the activity of the enzyme catalase. Catalase is a crucial antioxidant enzyme found in almost all living organisms, responsible for the breakdown of hydrogen peroxide (H2O2) into water and oxygen. This process is essential for protecting cells from oxidative damage caused by reactive oxygen species (ROS) such as H2O2.
The regulation of catalase activity can occur at various levels, including:
1. **Transcriptional Regulation:** The expression of the catalase gene can be induced by various stimuli, such as oxidative stress, heat shock, and heavy metal exposure. These stimuli activate specific transcription factors that bind to the promoter region of the catalase gene, leading to increased gene expression and subsequent catalase protein synthesis.
2. **Post-Translational Modifications:** Catalase activity can be modulated by post-translational modifications, including phosphorylation, acetylation, and ubiquitination. These modifications can alter the enzyme's stability, activity, and cellular localization. For example, phosphorylation of catalase can enhance its activity, while ubiquitination can target it for degradation.
3. **Interaction with Other Proteins:** Catalase interacts with other proteins that regulate its activity. For instance, some proteins act as chaperones, aiding in catalase folding and stability. Other proteins may function as cofactors or inhibitors, fine-tuning catalase activity based on cellular needs.
4. **Cellular Localization:** The subcellular localization of catalase can influence its activity. For example, catalase is primarily localized in peroxisomes, organelles that play a crucial role in detoxification. By sequestering catalase in peroxisomes, cells can efficiently eliminate H2O2 and protect other cellular compartments from oxidative stress.
The specific mechanisms involved in positive regulation of catalase activity can vary depending on the cell type and the stimuli encountered. However, the general principle remains the same: to increase the amount of active catalase in the cell to cope with increased levels of H2O2 and protect against oxidative damage.'
"
Protein | Definition | Taxonomy |
---|---|---|
NAD-dependent protein deacetylase sirtuin-3, mitochondrial | An NAD-dependent protein deacetylase sirtuin-3, mitochondrial that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9NTG7] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
niacinamide | nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group. | pyridine alkaloid; pyridinecarboxamide; vitamin B3 | anti-inflammatory agent; antioxidant; cofactor; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; Escherichia coli metabolite; geroprotector; human urinary metabolite; metabolite; mouse metabolite; neuroprotective agent; Saccharomyces cerevisiae metabolite; Sir2 inhibitor |
amiodarone | amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias. Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance. | 1-benzofurans; aromatic ketone; organoiodine compound; tertiary amino compound | cardiovascular drug |
ro 31-8220 | Ro 31-8220: a protein kinase C inhibitor | imidothiocarbamic ester; indoles; maleimides | EC 2.7.11.13 (protein kinase C) inhibitor |
honokiol | biphenyls | ||
4-methylnicotinamide | 4-methylnicotinamide: structure given in first source | ||
resveratrol | trans-resveratrol : A resveratrol in which the double bond has E configuration. | resveratrol | antioxidant; phytoalexin; plant metabolite; quorum sensing inhibitor; radical scavenger |
3-(1-azepanylsulfonyl)-n-(3-bromphenyl)benzamide | 3-(1-azepanylsulfonyl)-N-(3-bromphenyl)benzamide: a sirtuin 2 inhibitor; structure in first source | ||
cambinol | cambinol: inhibitor of human silent information regulator 2 enzymes; structure in first source | ||
(4-chlorophenyl)-[4-(8-nitro-5-quinolinyl)-1-piperazinyl]methanone | N-arylpiperazine | ||
ex 527 | 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide : A member of the class of carbazoles that is 2,3,4,9-tetrahydro-1H-carbazole which is substituted at position 1 by an aminocarbohyl group and at position 6 by a chlorine. 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide: structure in first source | carbazoles; monocarboxylic acid amide; organochlorine compound | |
panobinostat | panobinostat : A hydroxamic acid obtained by formal condensation of the carboxy group of (2E)-3-[4-({[2-(2-methylindol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enoic acid with the amino group of hydroxylamine. A histone deacetylase inhibitor used (as its lactate salt) in combination with bortezomib and dexamethasone for the treatment of multiple myeloma. Panobinostat: An indole and hydroxamic acid derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used as an antineoplastic agent in combination with BORTEZOMIB and DEXAMETHASONE for the treatment of MULTIPLE MYELOMA. | cinnamamides; hydroxamic acid; methylindole; secondary amino compound | angiogenesis modulating agent; antineoplastic agent; EC 3.5.1.98 (histone deacetylase) inhibitor |
quisinostat | indoles | ||
srt1460 | SRT1460: small molecule activator of SIRT1 as therapeutics for the treatment of type 2 diabetes; structure in first source | ||
srt1720 | |||
srt2183 | SRT2183: small molecule activator of SIRT1 as therapeutics for the treatment of type 2 diabetes; structure in first source | ||
tenovin-6 | tenovin-6 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-(dimethylamino)pentanoic acid with the aromatic amino group of N-[(4-aminophenyl)carbamothioyl]-4-tert-butylbenzamide. | monocarboxylic acid amide; tertiary amino compound; thioureas | antineoplastic agent; p53 activator; Sir2 inhibitor |
n-(3-((2-hydroxynaphthalen-1-ylmethylene)amino)phenyl)-2-phenylpropionamide |